Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Daiju, Ichikawa"'
Autor:
Mikio Okayama, Kota Fujimori, Mariko Sato, Koichi Samata, Koki Kurita, Hiromu Sugiyama, Yutaka Suto, Genji Iwasaki, Taketo Yamada, Fumiyuki Kiuchi, Daiju Ichikawa, Maiko Matsushita, Maki Hirao, Hisako Kunieda, Kohei Yamazaki, Yutaka Hattori
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 9749-9759 (2023)
Abstract Objective Despite the development of newly developed drugs, most multiple myeloma (MM) patients with high‐risk cytogenetic abnormalities such as t(4;14) or del17p relapse at anin early stage of their clinical course. We previously reported
Externí odkaz:
https://doaj.org/article/37aa41d432754590b8a64747c4ab0f1c
Autor:
Maiko Matsushita, Sho Kashiwazaki, Satoshi Kamiko, Michio Kobori, Makoto Osada, Hisako Kunieda, Maki Hirao, Daiju Ichikawa, Yutaka Hattori
Publikováno v:
Pharmaceuticals, Vol 16, Iss 10, p 1367 (2023)
Several anti-cancer drugs are known to have immunomodulatory effects, including immunogenic cell death (ICD) of cancer cells. ICD is a form of apoptosis which is caused by the release of damage-associated molecular patterns (DAMPs), the uptake of can
Externí odkaz:
https://doaj.org/article/d37f8f3348664981ba1064b1c4af38ba
Autor:
Mikio Okayama, Kota Fujimori, Mariko Sato, Koichi Samata, Koki Kurita, Hiromu Sugiyama, Yutaka Suto, Genji Iwasaki, Taketo Yamada, Fumiyuki Kiuchi, Daiju Ichikawa, Maiko Matsushita, Maki Hirao, Hisako Kunieda, Kohei Yamazaki, Yutaka Hattori
Publikováno v:
Cancer Medicine. 12:9749-9759
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e824901436a9262510fda55cc621864
https://doi.org/10.1002/cam4.5691
https://doi.org/10.1002/cam4.5691
Publikováno v:
Vaccines, Vol 8, Iss 4, p 579 (2020)
Despite the availability of therapeutic treatments, multiple myeloma is an incurable haematological disorder. In this study, we aimed to clarify the role of CXorf48 as a therapeutic target in multiple myeloma. Based on a previously identified HLA-A*2
Externí odkaz:
https://doaj.org/article/b41ded786dfb4c2894405d6d96f1ffda
Autor:
Suzuka, Tateno, Maki, Hirao, Takahide, Kikuchi, Yuiko, Tsukada, Hisako, Kunieda, Makoto, Osada, Kohei, Yamazaki, Ryunosuke, Denda, Shigemichi, Hirose, Maiko, Matsushita, Daiju, Ichikawa, Yutaka, Hattori
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 63(10)
An 82-year-old Japanese male patient was initially diagnosed with lymphocytosis. His complete blood count revealed a white blood cell count of 30.9×10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e567940a29b37a7a78703ede652f830c
https://pubmed.ncbi.nlm.nih.gov/36351649
https://pubmed.ncbi.nlm.nih.gov/36351649
Autor:
Kenichi Nagase, Akari Okada, Junnosuke Matsuda, Daiju Ichikawa, Yutaka Hattori, Hideko Kanazawa
Publikováno v:
Colloids and surfaces. B, Biointerfaces. 220
Adipose-derived mesenchymal stem cells (ADSCs) have beneficial effects in cell transplantation therapy; these cells are collected from adipose tissue using low-invasive methods. However, to prepare ADSCs for cell therapy, a cell separation method tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7121ae56d6f35db9a3e685fccd87da3b
https://pubmed.ncbi.nlm.nih.gov/36257279
https://pubmed.ncbi.nlm.nih.gov/36257279
Autor:
Yutaka Hattori, Hideko Kanazawa, Aya Mizutani Akimoto, Kenichi Nagase, Daiju Ichikawa, Saki Ishii, Koji Ikeda, Sota Yamada
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Scientific Reports
Scientific Reports
Antibody drugs play an important role in biopharmaceuticals, because of the specificity for target biomolecules and reduction of side effects. Thus, separation and analysis techniques for these antibody drugs have increased in importance. In the pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eed3659754c1aa8fa5163a636e8fe0b
http://link.springer.com/article/10.1038/s41598-020-68707-7
http://link.springer.com/article/10.1038/s41598-020-68707-7
Autor:
Maiko Matsushita, Yohei Otsuka, Naoya Tsutsumida, Chiaki Tanaka, Akane Uchiumi, Koji Ozawa, Takuma Suzuki, Daiju Ichikawa, Hiroyuki Aburatani, Shinichiro Okamoto, Yutaka Kawakami, Yutaka Hattori
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146371 (2016)
The homeobox protein, PEPP2 (RHOXF2), has been suggested as a cancer/testis (CT) antigen based on its expression pattern. However, the peptide epitope of PEPP2 that is recognized by cytotoxic T cells (CTLs) is unknown. In this study, we revealed that
Externí odkaz:
https://doaj.org/article/2e281ebf76ec4a299e44b2f4342b4a6a
Autor:
Yutaka Hattori, Maiko Matsushita, Wakana Murota, Daiju Ichikawa, Sho Osawa, Misa Nakamura, Hiroshi Yanagawa
Publikováno v:
Biochemical and Biophysical Research Communications. 521:252-258
To date, the prognosis of multiple myeloma (MM) in patients harboring cytogenetic abnormalities (CA) involving t (4; 14) and deletion of chromosome 17 remains poor despite recent advances in drug development that include the use of immunomodulatory d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ff090c120fdb461cd75bb14bb93f7f2
https://doi.org/10.1016/j.bbrc.2019.10.119
https://doi.org/10.1016/j.bbrc.2019.10.119
Autor:
Maiko Matsushita, Yoshie Ozaki, Yuka Hasegawa, Fukiko Terada, Noriko Tabata, Hirokazu Shiheido, Hiroshi Yanagawa, Tsukasa Oikawa, Koichi Matsuo, Wenlin Du, Taketo Yamada, Masashi Hozumi, Daiju Ichikawa, Yutaka Hattori
Publikováno v:
PLoS ONE, Vol 10, Iss 1, p e0116135 (2015)
Despite the recent advances in the treatment of multiple myeloma (MM), MM patients with high-risk cytogenetic changes such as t(4;14) translocation or deletion of chromosome 17 still have extremely poor prognoses. With the goal of helping these high-
Externí odkaz:
https://doaj.org/article/09bf3456f4c745db8b4addd92ca12040